AIP inactivation leads to pituitary tumorigenesis through defective Gαi-cAMP signaling
Authors:
- 24 March 2014
- journal article
- Published by Springer Nature in Oncogene
- Vol. 34 (9) , 1174-1184
Abstract
The aryl hydrocarbon receptor interacting protein (AIP) is a tumor-suppressor gene underlying the pituitary adenoma predisposition. Thus far, the exact molecular mechanisms by which inactivated AIP exerts its tumor-promoting action have been unclear. To better understand the role of AIP in pituitary tumorigenesis, we performed gene expression microarray analysis to examine changes between Aip wild-type and knockout mouse embryonic fibroblast (MEF) cell lines. Transcriptional analyses implied that Aip deficiency causes a dysfunction in cyclic adenosine monophosphate (cAMP) signaling, as well as impairments in signaling cascades associated with developmental and immune-inflammatory responses. In vitro experiments showed that AIP deficiency increases intracellular cAMP concentrations in both MEF and murine pituitary adenoma cell lines. Based on knockdown of various G protein α subunits, we concluded that AIP deficiency leads to elevated cAMP concentrations through defective Gαi-2 and Gαi-3 proteins that normally inhibit cAMP synthesis. Furthermore, immunostaining of Gαi-2 revealed that AIP deficiency is associated with a clear reduction in Gαi-2 protein expression levels in human and mouse growth hormone (GH)-secreting pituitary adenomas, thus indicating defective Gαi signaling in these tumors. By contrast, all prolactin-secreting tumors showed prominent Gαi-2 protein levels, irrespective of Aip mutation status. We additionally observed reduced expression of phosphorylated extracellular signal-regulated kinases 1/2 and cAMP response element-binding protein levels in mouse and human AIP-deficient somatotropinomas. This study implies for the first time that a failure to inhibit cAMP synthesis through dysfunctional Gαi signaling underlies the development of GH-secreting pituitary adenomas in AIP mutation carriers.Keywords
This publication has 69 references indexed in Scilit:
- PKA regulatory subunits mediate synergy among conserved G-protein-coupled receptor cascadesNature Communications, 2011
- Mutations inGNA11in Uveal MelanomaNew England Journal of Medicine, 2010
- Pituitary somatostatin receptor signalingTrends in Endocrinology & Metabolism, 2010
- G‐protein signalling negatively regulates the stability of aryl hydrocarbon receptorEMBO Reports, 2009
- Frequent somatic mutations of GNAQ in uveal melanoma and blue naeviNature, 2008
- Rat Prolactinoma Cell Growth Regulation by Epidermal Growth Factor Receptor LigandsCancer Research, 2008
- Regulation of cAMP Responses by the G12/13 Pathway Converges on Adenylyl Cyclase VIIJournal of Biological Chemistry, 2008
- Use of a cAMP BRET Sensor to Characterize a Novel Regulation of cAMP by the Sphingosine 1-Phosphate/G13 PathwayJournal of Biological Chemistry, 2007
- Molecular diagnosis of pituitary adenoma predisposition caused by aryl hydrocarbon receptor-interacting protein gene mutationsProceedings of the National Academy of Sciences, 2007
- An obligatory requirement for the heterotrimeric G protein G i3 in the antiautophagic action of insulin in the liverProceedings of the National Academy of Sciences, 2007